In vitro lytic activity and antifungal susceptibility of infrequently isolated yeasts

被引:3
作者
Montoya, Alexandra M. [1 ]
Luna-Rodriguez, Carolina E. [1 ]
Gracia-Robles, Gabriela [1 ]
Rojas, Olga C. [2 ]
Gonzalez, Gloria M. [1 ]
机构
[1] Univ Autonoma Nuevo Leon, Dept Microbiol, Fac Med, Ave Francisco I Madero S-N, Monterrey 64460, Mexico
[2] Univ Monterrey, Vicerectoria Ciencias Salud, Dept Ciencias Basicas, Ave Morones Prieto 4500 Pte, San Pedro Garza Garcia 66238, Mexico
关键词
Clavispora lusitaniae; Meyerozyma guilliermondii; Non-albicans Candida; Pichia kudriavzevii; Virulence; CANDIDA; RESISTANCE;
D O I
10.1007/s00203-019-01684-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Non-albicans Candida species have acquired relevance in the last decades as a cause of serious disease. The virulence factors and antifungal susceptibility of these rare pathogens remain largely unrecognized. We examined a total of 50 yeast isolates corresponding to 11 different infrequently isolated yeast species for their in vitro enzymatic profile and susceptibility pattern as first-line antifungals. We found aspartyl protease activity for 100% of the isolates tested as well as variable DNAse, hemolysin, phospholipase and esterase activities. All strains had low MICs for amphotericin B and showed a variable response to fluconazole (0.125-32 mu g/mL) and the echinocandins tested (0.25-> 8 mu g/mL).
引用
收藏
页码:1147 / 1149
页数:3
相关论文
共 16 条
  • [1] Rare yeasts causing fungemia in immunocompromised and haematology patients: Case series from Delhi
    Capoor, M. R.
    Gupta, D. K.
    Verma, P. K.
    Sachdeva, H. C.
    [J]. INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2015, 33 (04) : 576 - 579
  • [2] Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer
    Chitasombat, Maria N.
    Kofteridis, Diamantis P.
    Jiang, Ying
    Tarrand, Jeffrey
    Lewis, Russell E.
    Kontoyiannis, Dimitrios P.
    [J]. JOURNAL OF INFECTION, 2012, 64 (01) : 68 - 75
  • [3] Clinical and Laboratory Standards Institute, 2017, PERF STAND ANT SUSC
  • [4] Clinical and Laboratory Standards Institute, 2017, REF METH BROTH DIL A, V3rd
  • [5] De Salud S., 2016, Diagnostico y Tratamiento de Dislipidemias (Hipercolesterolemia) En El Adulto
  • [6] de Salud S., 2010, DIAGNOSTICO TRATAMIE
  • [7] Fernandez-Ruiz Mario, 2017, Med Mycol, V55, P125, DOI 10.1093/mmy/myw055
  • [8] Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry
    Horn, David L.
    Neofytos, Dionissios
    Anaissie, Elias J.
    Fishman, Jay A.
    Steinbach, William J.
    Olyaei, Ali J.
    Marr, Kieren A.
    Pfaller, Michael A.
    Chang, Chi-Hsing
    Webster, Karen M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (12) : 1695 - 1703
  • [9] Genotyping, extracellular compounds, and antifungal susceptibility testing of Trichosporon asahii isolated from Mexican patients
    Montoya, Alexandra M.
    Sanchez Gonzalez, Alejandro
    Palma-Nicolas, Jose P.
    Gomez-Trevino, Alberto
    Gonzalez, Jose G.
    Gonzalez, Gloria M.
    [J]. MEDICAL MYCOLOGY, 2015, 53 (05) : 505 - 511
  • [10] Pappas PG, 2016, CLIN INFECT DIS, V62, P409, DOI 10.1093/cid/civ1194